SQM Investors, You Need to Know These Facts Today.

Sociedad Quimica y Minera logged a -7.1% change during today's afternoon session, and is now trading at a price of $92.36 per share. The S&P 500 index moved 0.0% and the Dow Industrial Average posted a -0.6% change. SQM's trading volume is 1,663,784 compared to the stock's average volume of 1,666,480.

Sociedad Quimica y Minera trades -19.42% away from its average analyst target price of $114.62 per share. The 16 analysts following the stock have set target prices ranging from $80 to $141, and on average have given Sociedad Quimica y Minera a rating of buy.

If you are considering an investment in SQM, you'll want to know the following:

  • Sociedad Quimica y Minera's Graham number (a purchase price with a built-in margin of safety) is $51.95, which is 77.8% away from its current price

  • Sociedad Quimica y Minera has moved 54.1% over the last year, and the S&P 500 logged a change of -12.3%

  • Based on its trailing earning per share of 10.77, Sociedad Quimica y Minera has a trailing 12 month Price to Earnings (P/E) ratio of 8.6 while the S&P 500 average is 15.97

  • SQM has a forward P/E ratio of 6.8 based on its forward 12 month price to earnings (Eps) is $13.63 per share

  • The company has a price to earnings growth (PEG) ratio of 0.51 -- a number near or below 1 signifying that Sociedad Quimica y Minera is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 8.3 compared to its sector average of 1.86

  • Sociedad Química y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services.

  • Based in Santiago de Chile, the company has 6,081 full time employees and a market cap of $26,381,527,040. Sociedad Quimica y Minera currently returns an annual dividend yield of 0.1%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.